STNM01, the RNA oligonucleotide targeting carbohydrate sulfotransferase 15, as second-line therapy for chemotherapy-refractory patients with unresectable pancreatic cancer: An open label, phase I/IIa trial

  • Toshio Fujisawa
  • , Takayoshi Tsuchiya
  • , Motohiko Kato
  • , Masafumi Mizuide
  • , Kazuki Takakura
  • , Makoto Nishimura
  • , Hiromu Kutsumi
  • , Yoko Matsuda
  • , Tomio Arai
  • , Shomei Ryozawa
  • , Takao Itoi
  • , Hiroyuki Isayama
  • , Hideyuki Saya
  • , Naohisa Yahagi

Research output: Contribution to journalArticlepeer-review

14 Citations (Scopus)

Fingerprint

Dive into the research topics of 'STNM01, the RNA oligonucleotide targeting carbohydrate sulfotransferase 15, as second-line therapy for chemotherapy-refractory patients with unresectable pancreatic cancer: An open label, phase I/IIa trial'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Keyphrases